Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 6 | $28,256,065 |
Sells | 13 | $122,134,560 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
23 Jun 2023 17:36 | DICE | DICE Therapeutics Inc | NORTHPOND VENTURES GP, LLC | 10% | 22 Jun 2023 | Sale | 523,503 | 46.5 | 24,342,890 | I |
23 Jun 2023 17:36 | DICE | DICE Therapeutics Inc | NORTHPOND VENTURES GP, LLC | 10% | 22 Jun 2023 | Sale | 1,969,368 | 46.5 | 91,575,612 | I |
02 Jun 2023 20:11 | DICE | DICE Therapeutics Inc | JACOBSEN JOHN R. | CSO | 01 Jun 2023 | Sale | 4,443 | 31.24 | 138,799 | D |
02 Jun 2023 20:11 | DICE | DICE Therapeutics Inc | JACOBSEN JOHN R. | CSO | 01 Jun 2023 | Sale | 14,307 | 30.31 | 433,645 | D |
09 May 2023 18:02 | DICE | DICE Therapeutics Inc | SCHELLER RICHARD H | Director | 05 May 2023 | Sale | 84,097 | 38.5056 | 3,238,205 | D |
05 May 2023 17:19 | DICE | DICE Therapeutics Inc | ROBERTSON SCOTT M. | CFO & CBO | 03 May 2023 | Sale | 18,750 | 36.552 | 685,350 | D |
05 May 2023 17:10 | DICE | DICE Therapeutics Inc | TIMOTHY LU | CMO | 03 May 2023 | Sale | 10,000 | 36.5398 | 365,398 | D |
05 May 2023 17:03 | DICE | DICE Therapeutics Inc | JUDICE KEVIN | CEO | 03 May 2023 | Sale | 13,698 | 36.5 | 499,977 | D |
19 Apr 2023 19:28 | DICE | DICE Therapeutics Inc | JACOBSEN JOHN R. | CSO | 18 Apr 2023 | Sale | 16,392 | 30.0834 | 493,127 | D |
04 Apr 2023 17:31 | DICE | DICE Therapeutics Inc | JACOBSEN JOHN R. | CSO | 31 Mar 2023 | Sale | 773 | 30 | 23,190 | D |
30 Mar 2023 17:03 | DICE | DICE Therapeutics Inc | RA CAPITAL MANAGEMENT, L.P. | Director , 10% | 30 Mar 2023 | Purchase | 195,997 | 28.74 | 5,632,954 | I |
30 Mar 2023 17:03 | DICE | DICE Therapeutics Inc | RA CAPITAL MANAGEMENT, L.P. | Director , 10% | 29 Mar 2023 | Purchase | 66,369 | 29.38 | 1,949,921 | I |
30 Mar 2023 17:03 | DICE | DICE Therapeutics Inc | RA CAPITAL MANAGEMENT, L.P. | Director , 10% | 28 Mar 2023 | Purchase | 246,779 | 29.24 | 7,215,818 | I |
30 Mar 2023 16:35 | DICE | DICE Therapeutics Inc | JACOBSEN JOHN R. | CSO | 29 Mar 2023 | Sale | 1,094 | 30.0026 | 32,823 | D |
30 Mar 2023 16:35 | DICE | DICE Therapeutics Inc | JACOBSEN JOHN R. | CSO | 28 Mar 2023 | Sale | 500 | 30.0883 | 15,044 | D |
27 Mar 2023 17:01 | DICE | DICE Therapeutics Inc | RA CAPITAL MANAGEMENT, L.P. | Director , 10% | 27 Mar 2023 | Purchase | 151,132 | 27.48 | 4,153,107 | I |
27 Mar 2023 17:01 | DICE | DICE Therapeutics Inc | RA CAPITAL MANAGEMENT, L.P. | Director , 10% | 24 Mar 2023 | Purchase | 192,335 | 26.87 | 5,168,041 | I |
27 Mar 2023 17:01 | DICE | DICE Therapeutics Inc | RA CAPITAL MANAGEMENT, L.P. | Director , 10% | 23 Mar 2023 | Purchase | 155,089 | 26.67 | 4,136,224 | I |
21 Mar 2023 16:47 | DICE | DICE Therapeutics Inc | SCOPA JAMES PAUL | Director | 17 Mar 2023 | Sale | 10,000 | 29.05 | 290,500 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)